Barbara Sommer

Psychiatrist

Professional Education

Board Certification: Geriatric Psychiatry, American Board of Psychiatry and Neurology (1991)

Board Certification: Psychiatry, American Board of Psychiatry and Neurology (1985)

Fellowship: Massachusetts General Hospital and McLean Hospital - OCD Department (1985) MA

Residency: Tufts-New England Medical Center (1984) MA

Internship: Baystate Medical Center (1980) MA

Medical Education: New York Medical College (1979) NY

MD, New York Medical College, Medicine (1979)

Administrative Appointments

Member, Stanford Hospital Well Being of Physicians Committee, 2001

Member, Stanford Hospital Care Review Committee, 1997

Clinical Trials

Clinical trials are research studies that evaluate a new medical approach, device, drug, or other treatment. As a Stanford Hospital & Clinics patient, you have access to the latest, advanced clinical trials.

Open trials refer to studies currently accepting participants. Closed trials are not currently enrolling, but may open in the future.

Topiramate: Effects on cognition in patients with epilepsy, migraine headache and obesity
Sommer, B. R., Mitchell, E. L., & Wroolie, T. E. (2013). Topiramate: Effects on cognition in patients with epilepsy, migraine headache and obesity. THERAPEUTIC ADVANCES IN NEUROLOGICAL DISORDERS, 6(4), 211-227.

Treatment-resistant major depression and the capacity to terminate care
Sommer BR. (2010). Treatment-resistant major depression and the capacity to terminate care. Journal of Ethics in Mental Health, 5(1).

Review of topiramate for the treatment of epilepsy in elderly patients
Sommer, B. R., & FENN, H. H. (2010). Review of topiramate for the treatment of epilepsy in elderly patients. CLINICAL INTERVENTIONS IN AGING, 5, 89-99.

The efficacy, safety, and tolerability of donepezil for the treatment of young adults with Down syndrome
Kishnani PS, Sommer BS, Handen BL, Seltzer B, Capone GT, & et al. (2009). The efficacy, safety, and tolerability of donepezil for the treatment of young adults with Down syndrome. Am J Med Genetics, 149A(8).

Slower speed-of-processing of cognitive tasks is associated with presence of the apolipoprotein epsilon 4 allele
O'Hara, R., Sommer, B., Way, N., Kraemer, H. C., Taylor, J., & Murphy, G. (2008). Slower speed-of-processing of cognitive tasks is associated with presence of the apolipoprotein epsilon 4 allele. JOURNAL OF PSYCHIATRIC RESEARCH, 42(3), 199-204.

Safety and efficacy of anticonvulsants in elderly patients with psychiatric disorders: oxcarbazepine, topiramate and gabapentin
Sommer, B. R., Fenn, H. H., & Ketter, T. A. (2007). Safety and efficacy of anticonvulsants in elderly patients with psychiatric disorders: oxcarbazepine, topiramate and gabapentin. EXPERT OPINION ON DRUG SAFETY, 6(2), 133-145.

Role of psychiatric comorbidity on cognitive function during and after the menopausal transition
Alexander JL, & Sommer BR. (2007). Role of psychiatric comorbidity on cognitive function during and after the menopausal transition. Expert Rev Neurotherapeutics, 7(11).

Safety and tolerability of mood-stabilising anticonvulsants in the elderly
Fenn, H. H., Sommer, B. R., Ketter, T. A., & Alldredge, B. (2006). Safety and tolerability of mood-stabilising anticonvulsants in the elderly. EXPERT OPINION ON DRUG SAFETY, 5(3), 401-416.

The effect of oxybutynin treatment on cognition in children with diurnal incontinence
Sommer, B. R., O'Hara, R., Askari, N., Kraemer, H. C., & Kennedy, W. A. (2005). The effect of oxybutynin treatment on cognition in children with diurnal incontinence. JOURNAL OF UROLOGY, 173(6), 2125-2127.

Orange juice-induced hyperkalemia in schizophrenia
Berk DR, Conti PM, & Sommer BR. (2004). Orange juice-induced hyperkalemia in schizophrenia. Int J of Psychiatry in Medicine, 34(1).

Folic acid supplementation in dementia: A preliminary report
Sommer, B. R., Hoff, A. L., & Costa, M. (2003). Folic acid supplementation in dementia: A preliminary report. JOURNAL OF GERIATRIC PSYCHIATRY AND NEUROLOGY, 16(3), 156-159.

Safety of antidepressants in the elderly.
Sommer, B. R., Fenn, H., Pompei, P., DeBattista, C., Lembke, A., & Flores, B. (2003). Safety of antidepressants in the elderly. Expert opinion on drug safety, 2(4), 367-383.

Is dopamine administration possibly a risk factor for delirium?
Sommer, B. R., Wise, L. C., & Kraemer, H. C. (2002). Is dopamine administration possibly a risk factor for delirium?. CRITICAL CARE MEDICINE, 30(7), 1508-1511.

Gingko biloba and related compounds in Alzheimer?s disease
Sommer BR, & Schatzberg AF. (2002). Gingko biloba and related compounds in Alzheimer?s disease. Psychiatric Annals, 32(1).

Comparison of desipramine and cognitive/behavioral therapy in the treatment of elderly outpatients with mild-to-moderate depression
Thompson, L. W., Coon, D. W., Gallagher-Thompson, D., Sommer, B. R., & Koin, D. (2001). Comparison of desipramine and cognitive/behavioral therapy in the treatment of elderly outpatients with mild-to-moderate depression. AMERICAN JOURNAL OF GERIATRIC PSYCHIATRY, 9(3), 225-240.

Quetiapine-induced extrapyramidal side effects in patients with Parkinson's disease: Case report
Sommer, B. R. (2001). Quetiapine-induced extrapyramidal side effects in patients with Parkinson's disease: Case report. JOURNAL OF GERIATRIC PSYCHIATRY AND NEUROLOGY, 14(2), 99-100.

Naturalistic study of antipsychotic medications prescribed to elderly schizophrenic patients
Sommer BR, White L, Parrella M, Harvey PD, Knobler HY, & Masiar SJ. (1998). Naturalistic study of antipsychotic medications prescribed to elderly schizophrenic patients. Jrnl Prac Psych and Behav Hlth, 4(6).

Risperidone: Clinical outcome predictors and cost-effectiveness in a naturalistic setting
Finley PR, Sommer BR, Corbitt JL, Brunson GH, & Lum BL. (1998). Risperidone: Clinical outcome predictors and cost-effectiveness in a naturalistic setting. Psychopharmacology Bull, 34(1).

Syndrome of inappropriate antidiuretic hormone (SIADH) in an 80-year-old woman given clomipramine
Sommer, B. R. (1997). Syndrome of inappropriate antidiuretic hormone (SIADH) in an 80-year-old woman given clomipramine. AMERICAN JOURNAL OF GERIATRIC PSYCHIATRY, 5(3), 268-269.

Divalproex sodium for treatment of agitation in chronic psychiatric inpatients
Sommer BR, White L, Parrella M, Simon JM, & Masiar SJ. (1997). Divalproex sodium for treatment of agitation in chronic psychiatric inpatients. Jrnl Prac Psych and Behav Hlth, 3(5).

Changes in tardive dyskinesia symptoms in elderly patients treated with ganglioside GM1 or placebo.
Sommer, B. R., Cohen, B. M., Satlin, A., Cole, J. O., Jandorf, L., & Dorsey, F. (1994). Changes in tardive dyskinesia symptoms in elderly patients treated with ganglioside GM1 or placebo. Journal of geriatric psychiatry and neurology, 7(4), 234-237.

A case of baclofen-induced psychotic depression
Sommer BR, & Petrides G. (1992). A case of baclofen-induced psychotic depression. J Clin Psychiatry, 53.

Glycopyrrolate versus atropine in post-ECT amnesia in the elderly.
Sommer, B. R., Satlin, A., Friedman, L., & Cole, J. O. (1989). Glycopyrrolate versus atropine in post-ECT amnesia in the elderly. Journal of geriatric psychiatry and neurology, 2(1), 18-21.

METABOLISM OF THIORIDAZINE IN THE ELDERLY
Cohen, B. M., & Sommer, B. R. (1988). METABOLISM OF THIORIDAZINE IN THE ELDERLY. JOURNAL OF CLINICAL PSYCHOPHARMACOLOGY, 8(5), 336-339.

RBC FOLIC-ACID LEVELS AND COGNITIVE PERFORMANCE IN ELDERLY PATIENTS - A PRELIMINARY-REPORT
Sommer, B. R., & Wolkowitz, O. M. (1988). RBC FOLIC-ACID LEVELS AND COGNITIVE PERFORMANCE IN ELDERLY PATIENTS - A PRELIMINARY-REPORT. BIOLOGICAL PSYCHIATRY, 24(3), 352-354.

Plasma concentration of neuroleptic and serum prolactin in patients chronically receiving depot fluphenazine: No evidence of tolerance
Cohen BM, Chouinard G, Waternaux C, Schachter H, Jones B, & Sommer BR. (1987). Plasma concentration of neuroleptic and serum prolactin in patients chronically receiving depot fluphenazine: No evidence of tolerance. Human Psychopharmacology, 2.

PLASMA-LEVELS OF NEUROLEPTIC IN PATIENTS RECEIVING DEPOT FLUPHENAZINE
Cohen, B. M., Waternaux, C., Chouinard, G., Sommer, B. R., & Jones, B. (1985). PLASMA-LEVELS OF NEUROLEPTIC IN PATIENTS RECEIVING DEPOT FLUPHENAZINE. JOURNAL OF CLINICAL PSYCHOPHARMACOLOGY, 5(6), 328-332.

CIRCADIAN CHANGES IN THE DISTRIBUTION AND EFFECTS OF HALOPERIDOL IN THE RAT
Campbell, A., Herschel, M., Sommer, B., Madsen, J. R., Cohen, B. M., & BALDESSARINI, R. J. (1982). CIRCADIAN CHANGES IN THE DISTRIBUTION AND EFFECTS OF HALOPERIDOL IN THE RAT. NEUROPHARMACOLOGY, 21(7), 663-669.